The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1211
June 20, 2005
View Complete Issue         Table of Contents 2019 
Vagus Nerve Stimulation for Depression
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Vagus Nerve Stimulation for Depression
June 20, 2005 (Issue: 1211)
A device that stimulates the vagus nerve was approved by the FDA in July 1997 for treatment of refractory epilepsy and is now considered "approvable" for treatment-resistant depression.
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this article:
Title: Vagus Nerve Stimulation for Depression
Article code: 1211b
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.